Table 3.
ART in HIV-infected patients with cryptococcosis
| Time to start ART |
| Deferred until 5 weeks after the start of antifungal therapy |
| ART regimen |
| Consider drug–drug interactions between fluconazole and antiretroviral agents |
| Fluconazole may potentially increase PI concentrations, but no clinical significance |
| Fluconazole has the potential to increase NNRTI concentration |
| No significant interactions with efavirenz |
| Nevirapine has the most potential clinical relevancea |
| No significant interactions with rilpivirine |
| Monitor closely for nevirapine-associated adverse events, including hepatotoxicity |
aHIV-infected patients who received nevirapine, those also taking fluconazole 200 or 400 mg/day had nevirapine Cmin 76% higher, compared to those not taking fluconazole